ReShape Lifesciences Inc (NASDAQ:RSLS)

2.84
Delayed Data
As of 3:59pm ET
 -0.01 / -0.35%
Today’s Change
2.16
Today|||52-Week Range
32.31
-36.89%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for ReShape Lifesciences Inc have a median target of 10.25, with a high estimate of 10.25 and a low estimate of 10.25. The median estimate represents a +260.92% increase from the last price of 2.84.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in ReShape Lifesciences Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$4.0M
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.89%
 
 
 
 
 
 
Growthannually 70.65%
 
 
 
 
 
 

Sales

Growthquarterly 13.35%
 
 
 
 
 
 
Growthannually 863.48%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.